Contact
Please use this form to send email to PR contact of this press release:
GSK announces regulatory submission for umeclidinium monotherapy for COPD in Japan
TO:
Please use this form to send email to PR contact of this press release:
GSK announces regulatory submission for umeclidinium monotherapy for COPD in Japan
TO: